A carregar...
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer-related deaths worldwide. However, significant progress has been made individualizing therapy based on molecular aberrations (e.g., EGFR, ALK) and pathologic subtype. KRAS is one of the most frequently mutated genes in non-small cell lung cancer (NSCLC...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153335/ https://ncbi.nlm.nih.gov/pubmed/27807303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0084 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|